To determine whether silencing PRDX1 enhances NK cell cytotoxicity and reverses immune evasion by inhibiting glycolysis in HCC cells, we conducted a series of in vitro experiments. This evidence concerns the gene PRDX1 and hepatocellular carcinoma.